API0232999

Dapagliflozin

Dapagliflozin is an SGLT2 inhibitor and antidiabetic drug.

Product Size

Quantity

Pharm Gradet

Standard

Registration

Inquiry

API Description

API Details

Document

Related Patent Status

CAS No.

461432-26-8
Synonyms

Dapagliflozin; 461432-26-8; (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
CHEMBL ID

CHEMBL429910
Molecule Type

Small molecule
Compound CID

9887712

Molecular Weight (g/mol)

408.9
Molecular Formula

C21H25ClO6
InChI

InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1
InChIKey

JVHXJTBJCFBINQ-ADAARDCZSA-N
SMILES

CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl
IUPAC Name

(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
Exact Mass (Da)

408.1339662
Monoisotopic Mass (Da)

408.1339662

OUR PRODUCTS